Language selection

Search

Details for: GLN-GABAPENTIN

Company: GLENMARK PHARMACEUTICALS CANADA INC.

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02410990GLN-GABAPENTINGABAPENTIN600 MGTABLET (IMMEDIATE RELEASE)ORAL
02411008GLN-GABAPENTINGABAPENTIN800 MGTABLET (IMMEDIATE RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Gabapentin - Assessing the Potential Risk of Serious Breathing Problems

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: